MAP2K7 and pancreatic neoplasm: This increased level was sustained and increased in all cell lines by 48 hours and associated with corresponding inhibition of the activity of the activated RAF-MEK-ERK signaling pathway, as measured by decreased phosphorylated MEK and ERK levels in the pancreatic cancer cells (Figure 2A).